| News |
Reducing uncertainty in drug development: a Q&A with Thomas Helleday |
|
T cells are central drivers of inflammation across autoimmune and inflammatory diseases, yet current therapies inadequately target pathogenic T-cell pathways, limiting durable disease control.... Read more |
| Research Articles |
| Read our key publications |
| Educational videos |
| Journey into the body |
| Human Protein Atlas |
| The journey |